BBP
ETFis Series Trust I - Virtus LifeSci Biotech Products ETF

94
Loading...
Loading...
News
all
press releases
News Placeholder
Biotech ETFs Hovering Around a 52-Week: Here's Why
Biotech is back! Regulatory tailwinds, cheaper valuations, and Fed cut hopes are boosting ETFs like XBI and IBB. Is the rebound just starting?
Zacks·1mo ago
News Placeholder
Biotech ETFs Bounce Back in 2025: Here's Why
Biotech ETFs rally. IBB, ARKG, SBIO, BBC, CANC and BBP soar as Fed rate cut optimism, FDA approvals, deals and cheaper valuations drive the space in 2025.
Zacks·2mo ago

Latest BBP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.